Refractory Chronic Hand Eczema Responds to Oral Upadacitinib
Saved in:
Main Authors: | Nada Alghamdi, Abdullah AN.Aljalfan, Abdulmajeed S. Alharbi, Omar I.Alrubaish, Serene R.Almuhaidib |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2025-01-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | https://dpcj.org/index.php/dpc/article/view/4685 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Italian Expert Opinion on Chronic Hand Eczema: from Guidelines to Clinical Practice
by: Luca Stingeni, et al.
Published: (2024-11-01) -
Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01) -
Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01) -
Comparative study between efficacy of topical tofacitinib 2% ointment versus topical clobetasol propionate 0.05% ointment in hand eczema at a tertiary hospital in central India [version 1; peer review: 2 approved]
by: Dr Adarshlata Singh, et al.
Published: (2024-04-01) -
The management of severe eczema in pregnancy
by: E Keeling, et al.
Published: (2025-01-01)